These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19052182)

  • 1. Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy.
    Jardi R; Rodriguez-Frias F; Tabernero D; Homs M; Schaper M; Esteban R; Buti M
    J Clin Microbiol; 2009 Feb; 47(2):485-8. PubMed ID: 19052182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
    Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
    J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
    Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
    J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.
    Basaras M; Arrese E; Blanco S; Arroyo LS; Ruiz P; Cisterna R
    Intervirology; 2013; 56(3):190-4. PubMed ID: 23594698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.
    Niesters HG; Zoulim F; Pichoud C; Buti M; Shapiro F; D'Heuvaert N; Celis L; Doutreloigne J; Sablon E
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1283-9. PubMed ID: 20065049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus.
    Chantratita W; Song KS; Pongthanapisith V; Thongbaiphet N; Angkanavin K; Nimse SB; Sonawane MD; Kim T
    J Virol Methods; 2016 Nov; 237():58-63. PubMed ID: 27581951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
    Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
    Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
    Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
    J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
    Jang H; Kim J; Choi JJ; Son Y; Park H
    J Clin Microbiol; 2010 Sep; 48(9):3127-31. PubMed ID: 20573874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay.
    Mercier M; Laperche S; Girault A; Sureau C; Servant-Delmas A
    J Clin Microbiol; 2011 Mar; 49(3):1154-6. PubMed ID: 21177906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.
    Libbrecht E; Doutreloigne J; Van De Velde H; Yuen MF; Lai CL; Shapiro F; Sablon E
    J Clin Microbiol; 2007 Dec; 45(12):3935-41. PubMed ID: 17913933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
    Tadokoro K; Suzuki F; Kobayashi M; Yamaguchi T; Nagano M; Egashira T; Kumada H
    J Virol Methods; 2011 Jan; 171(1):67-73. PubMed ID: 20950650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.
    Aberle SW; Kletzmayr J; Watschinger B; Schmied B; Vetter N; Puchhammer-Stöckl E
    J Clin Microbiol; 2001 May; 39(5):1972-4. PubMed ID: 11326026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient.
    Guo JJ; Li QL; Shi XF; Zhang DZ; Zeng AZ; Feng T; Huang AL
    Antiviral Res; 2009 Feb; 81(2):180-3. PubMed ID: 18948142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates.
    Fang J; Wichroski MJ; Levine SM; Baldick CJ; Mazzucco CE; Walsh AW; Kienzle BK; Rose RE; Pokornowski KA; Colonno RJ; Tenney DJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2762-72. PubMed ID: 19433559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?
    Lee GH; Aung MO; Dan YY; Lee YM; Mak B; Low HC; Lim K; Thwin MA; Tan PS; Lim SG
    J Med Virol; 2013 Jan; 85(1):26-33. PubMed ID: 23023992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
    Hussain M; Fung S; Libbrecht E; Sablon E; Cursaro C; Andreone P; Lok AS
    J Clin Microbiol; 2006 Mar; 44(3):1094-7. PubMed ID: 16517902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.
    Osiowy C; Giles E
    J Clin Microbiol; 2003 Dec; 41(12):5473-7. PubMed ID: 14662927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance.
    Choi YJ; Kim HS; Lee SH; Park JS; Nam HS; Kim HJ; Kim CJ; Jeong DJ; Park KS; Baek KA
    Arch Virol; 2011 Sep; 156(9):1517-24. PubMed ID: 21594598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
    Lupo J; Larrat S; Hilleret MN; Germi R; Boyer V; Nicod S; Barguès G; Leroy V; Seigneurin JM; Zarski JP; Morand P
    J Virol Methods; 2009 Mar; 156(1-2):52-8. PubMed ID: 19041345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.